Supplementary Materials

The PDF file includes:

  • Materials and Methods
  • Fig. S1. Comparative phenotypic analysis of T cell populations from WT and Csf2−/− mice.
  • Fig. S2. GM-CSF is crucial for acute GvHD after fully MHC-mismatched allo-HCT.
  • Fig. S3. GM-CSF mediates GvHD pathology after partially MHC-mismatched allo-HCT.
  • Fig. S4. GM-CSF drives GvHD through donor-derived myeloid cells.
  • Fig. S5. GM-CSF is dispensable for antitumor activity after allo-HCT.
  • Fig. S6. Frequency of cytokine-expressing T cells in PBMCs of patients with GvHD.
  • Table S1. Clinicopathological features of GvHD patient set I.
  • Table S2. Clinicopathological features of GvHD patient set II.
  • Table S3. Characteristics of control subjects.
  • Table S4. Clinicopathological features of GvHD patient PBMCs.
  • Legend for table S5
  • Table S6. GvHD scoring system for allo-HCT mice.
  • Table S7. Phenotypic analysis of human PBMCs by flow cytometry.

[Download PDF]

Other Supplementary Material for this manuscript includes the following:

  • Table S5 (Microsoft Excel format). Primary data.